Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Autor: Goldkorn A; Division of Medical Oncology, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.; USC Norris Comprehensive Cancer Center, Los Angeles, California., Tangen C; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington., Plets M; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington., Bsteh D; Division of Medical Oncology, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.; USC Norris Comprehensive Cancer Center, Los Angeles, California., Xu T; Division of Medical Oncology, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.; USC Norris Comprehensive Cancer Center, Los Angeles, California., Pinski JK; USC Norris Comprehensive Cancer Center, Los Angeles, California., Ingles S; Keck School of Medicine of USC, Los Angeles, California., Triche TJ; Children's Hospital Los Angeles, University of Southern California, Los Angeles., MacVicar GR; Illinois CancerCare PC, Peoria., Vaena DA; Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City., Crispino AW; UsTOO Las Vegas, Las Vegas, Nevada., McConkey DJ; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, Maryland., Lara PN Jr; UC Davis Comprehensive Cancer Center, Sacramento, California., Hussain MHA; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Quinn DI; USC Norris Comprehensive Cancer Center, Los Angeles, California., Dorff TB; City of Hope Comprehensive Cancer Center, Duarte, California., Lerner SP; Scott Department of Urology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Thompson I Jr; Christus Health, San Antonio, Texas., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Oct 01; Vol. 7 (10), pp. e2437871. Date of Electronic Publication: 2024 Oct 01.

Prevention of prostate cancer: outcomes of clinical trials and future opportunities.

Autor: Thompson I Jr; From the Cancer Therapy and Research Center, University of Texas HSC at San Antonio, San Antonio, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Bloomberg School of Public Health and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Kristal A; From the Cancer Therapy and Research Center, University of Texas HSC at San Antonio, San Antonio, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Bloomberg School of Public Health and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Platz EA; From the Cancer Therapy and Research Center, University of Texas HSC at San Antonio, San Antonio, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; and Johns Hopkins Bloomberg School of Public Health and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

Publikováno v: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2014, pp. e76-80.

Follow-up of conservatively managed prostate cancer: watchful waiting and primary hormonal therapy.

Autor: Messing EM; Department of Urology, University of Rochester, 601 Elmwood Avenue, Box 656, Rochester, NY 14642, USA. edward_messing@urmc.rochester.edu, Thompson I Jr

Publikováno v: The Urologic clinics of North America [Urol Clin North Am] 2003 Nov; Vol. 30 (4), pp. 687-702, viii.